Composition and dosage form comprising a particle...

Details Composition and dosage form comprising a particle... Composition and dosage form comprising a particle...

2011-06-21

2011-06-21

Hui, San-Ming (Department: 1628)

Drug, bio-affecting and body treating compositions

Lymphokine

C424S422000, C514S005900, C514S007200, C514S007600, C514S011400

Reexamination Certificate

active

07964183

ABSTRACT:
A liquid composition in an osmotic drug delivery system and a dosage form in an osmotic drug delivery system is disclosed comprising an amphiphilic molecule, a non-aqueous liquid solvent, and a pharmaceutically active agent.

REFERENCES:
patent: 4111201 (1978-09-01), Theeuwes
patent: 4743449 (1988-05-01), Yoshida et al.
patent: 5091188 (1992-02-01), Haynes
patent: 5278151 (1994-01-01), Korb et al.
patent: 5324280 (1994-06-01), Wong et al.
patent: 5660858 (1997-08-01), Parikh et al.
patent: 5728396 (1998-03-01), Peery et al.
patent: 5904935 (1999-05-01), Eckenhoff et al.
patent: 5932547 (1999-08-01), Stevenson et al.
patent: 5972370 (1999-10-01), Eckenhoff et al.
patent: 5997527 (1999-12-01), Gumucio et al.
patent: 6022561 (2000-02-01), Carlsson et al.
patent: 6113938 (2000-09-01), Chen et al.
patent: 6124261 (2000-09-01), Stevenson et al.
patent: 6130200 (2000-10-01), Brodbeck et al.
patent: 6132420 (2000-10-01), Dionne et al.
patent: 6133249 (2000-10-01), Hills
patent: 6174547 (2001-01-01), Dong et al.
patent: 6235712 (2001-05-01), Stevenson et al.
patent: 6258377 (2001-07-01), New et al.
patent: 6270787 (2001-08-01), Ayer
patent: 6287295 (2001-09-01), Chen et al.
patent: 6331311 (2001-12-01), Brodbeck et al.
patent: 6375978 (2002-04-01), Kleiner et al.
patent: 6419952 (2002-07-01), Wong et al.
patent: 6433144 (2002-08-01), Morris et al.
patent: 6461605 (2002-10-01), Cutler et al.
patent: 6468961 (2002-10-01), Brodbeck et al.
patent: 6485706 (2002-11-01), McCoy et al.
patent: 6508808 (2003-01-01), Carr et al.
patent: 6524305 (2003-02-01), Peterson et al.
patent: 6544252 (2003-04-01), Theeuwes et al.
patent: 6551613 (2003-04-01), Dong et al.
patent: 6673767 (2004-01-01), Brodbeck et al.
patent: 6939556 (2005-09-01), Lautenbach
patent: 7014636 (2006-03-01), Gilbert
patent: 7074423 (2006-07-01), Fereira et al.
patent: 7163688 (2007-01-01), Peery et al.
patent: 7207982 (2007-04-01), Dionne et al.
patent: 7258869 (2007-08-01), Berry et al.
patent: 7731947 (2010-06-01), Eliaz et al.
patent: 2003/0059376 (2003-03-01), Libbey, III et al.
patent: 2004/0224903 (2004-11-01), Berry et al.
patent: 2005/0008661 (2005-01-01), Fereira et al.
patent: 2005/0112188 (2005-05-01), Eliaz et al.
patent: 2005/0175701 (2005-08-01), Pan et al.
patent: 2005/0266087 (2005-12-01), Junnarkar et al.
patent: 2005/0276856 (2005-12-01), Fereira et al.
patent: 2006/0193918 (2006-08-01), Rohloff et al.
patent: 2006/0216242 (2006-09-01), Rohloff et al.
patent: 2006/0246138 (2006-11-01), Rohloff et al.
patent: 2006/0251618 (2006-11-01), Dennis et al.
patent: 2007/0027105 (2007-02-01), Junnarkar et al.
patent: 2007/0281024 (2007-12-01), Lautenbach et al.
patent: 0 729 747 (1997-05-01), None
patent: 0 771 817 (1997-05-01), None
patent: 9-241153 (1997-09-01), None
patent: 11-100353 (1999-04-01), None
patent: WO 93/06819 (1993-04-01), None
patent: WO 97/15289 (1997-05-01), None
patent: WO 97/46204 (1997-12-01), None
patent: WO 98/32463 (1998-07-01), None
patent: WO 98/47487 (1998-10-01), None
patent: WO 99/16419 (1999-04-01), None
patent: WO 99/39700 (1999-08-01), None
patent: WO 00/45790 (2000-08-01), None
patent: WO 00/67728 (2000-11-01), None
patent: WO 02/45752 (2002-06-01), None
patent: WO 02/069983 (2002-09-01), None
patent: WO 03/053400 (2003-07-01), None
Bakan, D. et al., “Physicochemical Characterization of a Synthetic Lipid Emulsion for Hepatocyte-Selective Delivery of Lipophilic Compounds: Application to Polyiodinated triglycerides as Contrast Agents for Compound Tomography”,Journal of Pharmaceutical Science, 1996, 85(9), 908-914.
Cantor, R.S., “Theory of Lipid Monolayers Comprised of Mixtures of Flexible and Stiff Amphiphiles in Anthermal Solvents: Fluid Phase Coexistence”,The Journal of Chemical Physics, 1996, 104(20), 8082-8095.
Chapman, D. et al., “Physical Studies of Phospholipids. VI. Thermotropic and Lyotropic Mesomorphism of Some 1,2-Diacylphosphatidylcholines (lecithins)”,Chemistry and Physics of Lipids, 1967, 1(5), 445-475.
Felker, T.E. et al., “The Rate of Transfer of Unesterified Cholesterol from Rat Erythrocytes to Emulsions Modeling NascentTriglyceride-Rich Lipoproteins and Chylomicrons Depends on the Degree of Fluidity of the Surface”,The Journal of Nutritional Biochemistry, 1993, 4(1), 630-634.
Kabalnov, A. et al, “Phospholipids as Emulsion Stabilizers.2. Phase Behavior Versus Emulsion Stability”,Journal of Colloid and Interface Science, 1996, 184(1), 227-235.
Kabalnov, A. et al., “Macroemulsion Type and Stability of Alkane-Water-Phospholipid Systems”,Book of Abstracts, 210thACS National Meeting, Chicago, Il, Aug. 20-24, 1995, Issue Pt 1.
Massey, John B., “Interaction of Vitamin E with Saturated Phospholipid Bilayers”,Biochemical and Biophysical Research Communications, 1982, 106(3), 842-847.
Wang, X. et al., “Preferential Interaction of α-tocopherol with Phosphatidylcholines in Mixed Aqueous Dispersions of Phosphatidylcholine and Phosphatidylethanolamine”,European Journal of Biochemistry, 2000, 267(21), 6362-6368.
Wang, X. et al., “Ripple Phases Induced by α-Tocopherol in Saturated Diacylphosphatidylcholines”,Archives of Biochemistry and Biophysics, 2000, 377(2), 304-314.
Wang, X.Y. et al., “The Distribution of α-Tocopherol in Mixed Aqueous Dispersions of Phosphatidyleholine and Phosphattidylethanolamine”,Biochimica et Biophysica Acta-Biomembranes, 2000, 1509(1-2), 361-372.
Jain, R.A. et al., “Controlled Delivery of Drugs from a Novel Injectable in Situ Formed Biodegradable PLGA Microsphere System”,Journal of Microencapsulation, 2000, 17(3), 343-362.
Fujii, M. et al., “Effect ofphosphatidylcholineon Skin Permeation of Indomethacin from gel prepared with Liquid Paraffin and Hydrogenated Phospholipid”,International Journal of Pharmaceutics, 2001, 222(1), 57-64.
Fujii, M. et al., Enhancement of Skin Permeation of Miconazole by Phospholipid and Dodecyl 2-(N, N-dimethylamino) Propionate (DDAIP),International Journal of Pharmaceutics, 2002, 234(1-2), 121-128.
Schmalfuβ, U. et al., “Modification of Drug Penetration into Human Skin Using Microemulsions”,Journal of Controlled Release, 1997, 46(3), 279-285.
Erõs, I. et al., “Multiple Phase Emulsions as Controlled Drug Delivery Therapeutic Systems”,Proc.-Conf. Colloid Chem., 1993, 6thMeeting Date, 193-196.
Nordén, T.P. et al., “Physicochemical Characterization of a Drug-Containing Phospholipid-Stabilized o/w Emulsion for Intravenous Administration”,European Journal of Pharmaceutical Sciences, 2001, 13(4), 393-401.
Bakhtiar, C. et al, Taking Delivery. (Ingredients: Liposomes). (liposomes in cosmetic delivery systems),Soap Perfumery&Cosmetics, 2003, 76(3), 59(4).
Das, S. et al., “Reviewing Antisense Oligonucleotide Therapy: Part 2, Delivery Issues”,BioPharm, Nov. 1999, 12(11), 44.
Larsson, K., “Stability of Emulsions Formed by Polar Lipids”,Progress in the Chemistry of Fats and Other Lipids, 1978, 16, 163-169.
Ortiz, A. et al., A Differential Scanning Calorimetry Study of the Interaction of α-Tocopherolwith Mixtures of Phospholipids,Biochim et Biophys Acta, 1987, 898(2), 214-222.
Lundberg, B.., “A Submicron Lipid Emulsion Coated with Amphipathic Polyethylene Glycol for Parenteral Administration of Paclitaxel (Taxol)”,The Journal of Pharmacy and Pharmacology, 1997, 49(1), 16-21.
Hodoshima, N. et al., “Lipid Nanoparticles for Delivering AntitumorDrugs”, International Journal of Pharmaceutics, 1997, 146(1), 81-92.
Quintanar Guerrero D. et al., “Applications of the Ion-Pair Concept to Hydrophilic Substances with Special Emphasis on Peptides”,Pharmaceutical Research, 1997, 14(2), 119-127.
Bauer, K.H. et al., “Non Aqueous Emulsions as Vehicles for Capsule Fillings”,Drug Development and Industrial Pharmacy, 1984, 10(5), 699-712.
Bohlinder, K. et al., “Use and Characteristics of a Novel Lipid Particle-Forming Matrix as a

Affiliated with

Also associated with

Rating

Composition and dosage form comprising a particle... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition and dosage form comprising a particle..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and dosage form comprising a particle... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2706004